STOCK TITAN

2,959 AGIO shares tied to RSU vesting (NASDAQ: AGIO) — Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 reporting a proposed resale related to the vesting of 2,959 Restricted Stock Units into Common Stock. The vesting and proposed sale date is 03/05/2026, and the shares are listed on Nasdaq.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a small, routine resale tied to RSU vesting.

The filing shows 2,959 shares of Common Stock becoming sellable on 03/05/2026 due to the vesting of Restricted Stock Units. This is a notice of a proposed sale rather than evidence of executed market trades.

Cash‑flow treatment and the selling party's identity beyond the filer are not detailed in the excerpt; subsequent filings or broker reports may show actual transactions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does AGIO's Form 144 report?

It reports a proposed resale of 2,959 shares of Common Stock tied to RSU vesting on 03/05/2026. The filing is a notice of intent to sell rather than confirmation of a completed sale.

Who is listed as the filer on the AGIO Form 144?

Morgan Stanley Smith Barney LLC Executive Financial Services is listed as the filer in the excerpt. The filing shows the broker-dealer address and Nasdaq as the listing exchange.

Are the 2,959 shares already sold according to the filing?

No. The Form 144 excerpt indicates a proposed resale connected to the vesting of RSUs on 03/05/2026. It does not confirm that the shares have been sold in the market.

Does the Form 144 state who receives proceeds from any sale?

The excerpt does not specify who will receive sale proceeds. The filing lists the resale event tied to RSU vesting but does not detail cash‑flow recipients or use of proceeds.

What exchange are the shares listed on in the filing?

The filing indicates the Common Stock is listed on Nasdaq. The excerpt includes the listing exchange field alongside the share counts and date.
Agios Pharmaceuticals Inc

NASDAQ:AGIO

View AGIO Stock Overview

AGIO Rankings

AGIO Latest News

AGIO Latest SEC Filings

AGIO Stock Data

1.62B
55.75M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE